title: Leukemoid reaction in sarcomatoid renal cell carcinoma: a two-case report.
abstract: Leukemoid reaction is defined as reactive leukocytosis exceeding 40 × 10⁹/l, with a significant increase in early neutrophil precursors, and can be a paraneoplastic manifestation of various malignant tumors. Leukemoid reaction is a sign for poor prognosis in solid tumors so is sarcomatoid renal cell carcinoma (SRCC) when compared to more differentiated histologies. Here, we are reporting two cases of leukemoid reaction after radical nephrectomy, both of which were diagnosed as SRCC pathologically. The operations were successful: no complications were observed and the patients were discharged in good condition. However, a few weeks later, the white blood cell (WBC) count gradually increased. Even though routine management was done immediately, the count was still elevating. A diagnosis of a leukemoid reaction was established and both of them died shortly thereafter. Due to the poor prognosis of most patients with malignant leukemoid reaction, leukemoid reaction may be a predictor of prognosis in patients with SRCC, but more data are needed.
authors.forename: Weiping
authors.initials: W
authors.lastname: Huang
authors.forename: Feng
authors.initials: F
authors.lastname: Wang
authors.forename: Yeping
authors.initials: Y
authors.lastname: Li
authors.forename: Feifei
authors.initials: F
authors.lastname: Duan
authors.affiliation: Department of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, ShangCai Village, Wenzhou, Ou Hai District, China. fengyuan-@163.com.
authors.forename: Zhixian
authors.initials: Z
authors.lastname: Yu
mesh_terms: D000328:Adult; D002292:Carcinoma, Renal Cell / Q000150:complications* / Q000473:pathology; D005260:Female; D006801:Humans; D007955:Leukemoid Reaction / Q000175:diagnosis* / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy / Q000009:adverse effects*; D011379:Prognosis
references.citation: J Assoc Physicians India. 1990 Feb;38(2):179-80
references.pmid: 2380139
references.citation: Am J Surg Pathol. 2003 May;27(5):612-24
references.pmid: 12717246
references.citation: Hinyokika Kiyo. 2011 Nov;57(11):615-8
references.pmid: 22166824
references.citation: Rom J Morphol Embryol. 2009;50(4):701-5
references.pmid: 19942969
references.citation: Eur J Intern Med. 2006 Oct;17(6):394-8
references.pmid: 16962944
references.citation: Eur Rev Med Pharmacol Sci. 2012 Dec;16(14):1895-9
references.pmid: 23242713
references.citation: Invest New Drugs. 2010 Oct;28(5):703-13
references.pmid: 19590824
references.citation: Am J Surg Pathol. 2001 Mar;25(3):275-84
references.pmid: 11224597
references.citation: JOP. 2006 Nov 10;7(6):631-4
references.pmid: 17095843
references.citation: Cancer Res. 1995 Aug 1;55(15):3438-43
references.pmid: 7542171
references.citation: Clin Exp Immunol. 2012 Jan;167(1):73-83
references.pmid: 22132887
references.citation: J Urol. 2002 Jan;167(1):65-70
references.pmid: 11743277
references.citation: J Laryngol Otol. 1997 Jan;111(1):66-9
references.pmid: 9292137
references.citation: N Engl J Med. 1992 Jul 9;327(2):99-106
references.pmid: 1376442
references.citation: J Med Case Rep. 2012 Jul 19;6:211
references.pmid: 22812671
references.citation: J Clin Oncol. 2009 Dec 1;27(34):e215-7
references.pmid: 19786665